Former Bayer ANZ access leader joins global bio-revolution
By Megan Brodie 5 years ago | In Cell and gene therapies, Companies, People- 5 years ago
Bayer's Matt Slabbert
21 May 2021 Former Bayer ANZ Head of Market Access, Advocacy and Policy Matt Slabbert…
This is subscriber-only content. Please login to continue reading.